Are the NCCN/SSO COVID-19 guidelines for delay in melanoma treatment associated with mortality risk?: Supplemental Files

Published: 2 July 2020| Version 2 | DOI: 10.17632/wyx96j2pcj.2
Contributor:
Samantha Guhan

Description

Supplemental material for publication titled - "Are the NCCN/SSO COVID-19 guidelines for delay in melanoma treatment associated with mortality risk?" to be published in Journal of the American Academy of Dermatology

Files